FDA OKs Leucovorin for Rare Genetic Disorder, but Not Autism

by | Mar 10, 2026 | Health

Spread the love
The FDA approved leucovorin for cerebral folate deficiency linked to FOLR1 mutations but said evidence is insufficient to support approval for autism.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments